ESR1 and breast neoplasm: BRRIAR was more highly expressed in luminal A and luminal B (predominantly ER+) breast tumor subtypes in TCGA (Fig. 1c) [21], and showed a moderate positive correlation with ESR1 expression in these subtypes (Spearman’s r = 0.37, p = 2.15e-28).